Organigram Global Inc. (OGI) Research

Organigram Global Inc., primarily operating through its subsidiary Organigram Holdings Inc., is a Canadian enterprise specializing in the cultivation, production, and distribution of cannabis and related products. The company serves the medical cannabis market by offering products such as cannabis flowers, oils, and vaporizing devices to both civilian patients and military veterans. For adult recreational consumers, Organigram provides a diverse range of cannabis products, including edibles and concentrates, under popular brands like Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour. Additionally, the company acts as a wholesale supplier, distributing cannabis plant cuttings, dried flowers, proprietary blends, pre-rolled products, and various cannabis derivatives to retailers and other wholesalers within the adult-use recreational sector. Customers can purchase Organigram's offerings through its online platform or via telephone orders. Established in 2013, the company's corporate headquarters are located in Moncton, Canada.

Market snapshot

Symbol
OGI
Price
$0.96
Day change
-2.28%
Market cap
$188.3M
P/E ratio
-7.20x
52-week range
0.95-2.24
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 2 months

Recent news

  • Organigram Says Vape Weakness Pressures Margins

    Organigram Global Inc. (NASDAQ:OGI) reported weaker second-quarter fiscal 2026 results as declining vape and infused pre-roll sales weighed on revenue and profitability.

Peer companies

  • Aurora Cannabis Inc. (ACB)
  • Journey Medical Corporation (DERM)
  • Electromed, Inc. (ELMD)
  • Solana Company (HSDT)
  • InfuSystem Holdings, Inc. (INFU)
  • Inventiva S.A. (IVA)
  • Lifecore Biomedical, Inc. (LFCR)
  • Orchestra BioMed Holdings, Inc. (OBIO)

Open Organigram Global Inc. (OGI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.